Chris Cairns found not guilty in perjury case ... Read more

Pacific Edge US lab completed

Last updated 11:16 17/10/2012
PEB 0.415 -0.02 -3.49%

Click for a detailed chart

Relevant offers


Two New Zealand wines win trophies at International Wine and Spirit Competition $56m police payroll project in trouble, says Treasury report Dwelling consents at 11-year high, but not high enough in Auckland, economists warn Family farms our future agri powerhouses: CANNZ paper Victory for Feilding meatworkers, with more work to do Finance diary 2000 broken hopes at failed Wellington call centre Hawke's Bay syrah wins top trophy at Air New Zealand Wine Awards Health drink SOS Hydration seeks to raise $2.3m in crowdfunding campaign AFT Pharmaceuticals NZX and ASX listing to fund growth

Shares in Pacific Edge rose today as it announced it has completed its US$3.7 million (NZ$4.5m) laboratory in the United States on-schedule and within budget.

Pacific Edge is forecasting more than $100m of gross revenues from its US operations in the five years after the new Hershey, Pennsylvania base starts processing in March.

So far the NZX-listed cancer diagnostic company's revenues remain very small and were not disclosed in its year to March 31, 2012 result.

In morning trade Pacific Edge shares were 3 cents or 7.5 per cent higher at 43 cents.

New Zealand chief executive David Darling today said Pacific Edge was now preparing for US registration under the clinical laboratory improvement amendments regulations.

The purpose-built laboratory in Hershey was expected to complete regulatory approval and be fully operational in March 2013 to offer Pacific Edge's bladder cancer diagnostic test.

Pacific Edge is investing in the commercialisation of its Cxbladder product, a diagnostic test for the detection of bladder cancer. It is offering the cancer laboratory test to clinicians throughout the US.

Darling said the laboratory, with a capacity of 260,000 tests a year, would be operated by a wholly owned subsidiary of the company, Pacific Edge Diagnostics USA Limited.

"The demanding timetable to launch this business is being met and the focus of the US team led by Jackie Walker is now on completion of the regulatory approvals, sales force deployment and marketing roll-out."

The US was the world's largest healthcare market, with its 17,000 urologists making it Pacific Edge's most important market, he added.

Ad Feedback


Special offers

Featured Promotions

Sponsored Content